Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens
| Autor: | Fehres, Cynthia M. a, Kalay, Hakan a, Bruijns, Sven C.M. a, Musaafir, Sara A.M. a, Ambrosini, Martino a, van Bloois, Louis b, van Vliet, Sandra J. a, Storm, Gert b, c, Garcia-Vallejo, Juan J. a, van Kooyk, Yvette a, ⁎ |
|---|---|
| Zdroj: | In Journal of Controlled Release 10 April 2015 203:67-76 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect